Daytime Urinary Incontinence in Children Algorithm

Safety

Red Flags — Neurological Bladder, Spinal Pathology & Abuse

Done

Scope: This pathway covers children with daytime lower urinary tract symptoms, including daytime urinary incontinence, urgency, frequency, dysfunctional voiding and bladder–bowel dysfunction. It does not replace the separate NICE pathway for monosymptomatic nocturnal enuresis (NICE CG111 does not cover daytime wetting in full).

New urinary incontinence with back pain, progressive leg weakness, gait disturbance, sensory change, saddle anaesthesia, abnormal reflexes or other neurological signs Also: acute urinary retention, loss of anal tone, rapidly progressive symptoms, fever or systemic illness suggesting spinal infection, known spinal dysraphism or neurological disease. Spinal cord pathology — tethered spinal cord, spinal tumour, transverse myelitis, infection. → Same-day emergency paediatric assessment; spinal imaging arranged through the emergency/paediatric team.

Continuous dribbling incontinence in a girl from birth (never dry) + normal voiding pattern Ectopic ureter (opens below the external sphincter, into vaginal vestibule or uterus). → Prompt paediatric urology referral; imaging as directed by the specialist team.

Daytime incontinence + recurrent UTIs + haematuria + abnormal urine stream (poor flow in boys, or intermittent) Posterior urethral valves (boys) or vesicoureteric reflux (VUR) with bladder dysfunction. → Paediatric urology / nephrology referral; renal/bladder ultrasound per the NICE NG224 imaging pathway. MCUG is a specialist investigation, not routine. Suspected obstructive uropathy (poor stream, palpable bladder, renal impairment) → urgent same-day. Risk of progressive renal scarring.

Daytime incontinence + recent onset + polydipsia + polyuria + weight loss New-onset type 1 diabetes mellitus. → Capillary blood glucose + urine dipstick (glycosuria + ketonuria) now. Suspected type 1 diabetes → refer the same day to the paediatric diabetes team (NICE NG18) — do not wait for HbA1c or laboratory tests; 999 if drowsy, vomiting or breathless (suspected DKA). Do not miss this diagnosis.

Safeguarding concern — disclosure, injuries, behavioural change, genital symptoms or concerning context Urinary incontinence is non-specific and is not evidence of abuse by itself. → If abuse is suspected, prioritise immediate safeguarding assessment. Do not lead the child, repeatedly question them or perform an unnecessary/inappropriate genital or anal examination. Record the child’s words verbatim where possible and contact the local safeguarding team/MASH and paediatric safeguarding lead. Any forensic examination should be arranged through the appropriate specialist pathway.

Incontinence + constipation (hard stools, <3/week) + soiling + abdominal mass Loaded colon (severe constipation) compressing the bladder — extremely common but often missed. → Treat constipation first (macrogol per current CG99/product-specific regimen). Bladder symptoms may improve once constipation is treated.

Daytime urinary incontinence in a previously continent child (secondary incontinence) or persistent incontinence beyond the expected age of continence (primary incontinence) is a common paediatric presentation in UK primary care. The critical diagnostic distinction is between primary daytime incontinence (the child has never achieved reliable daytime dryness) and secondary daytime incontinence (new onset after a period of dryness). Secondary incontinence is a red flag requiring investigation for: UTI, constipation, emotional stress, safeguarding concerns (incontinence alone is non-specific), diabetes mellitus, and neurological or anatomical causes. Primary daytime incontinence beyond the usual toilet-training period most commonly results from overactive bladder (OAB) or dysfunctional voiding — both highly treatable conditions. The GP's role is to identify the dangerous causes, then manage or refer appropriately for the common functional causes.

Diagnose

Normal Bladder Development & Age of Continence

Done

Normal bladder development milestones

Birth–2 years: reflex voiding — no cortical control. 2–3 years: child becomes aware of bladder sensations and shows toilet-training readiness. Most children acquire daytime continence by around 4 years, but there is developmental variation. Assess when: daytime wetting beyond the usual toilet-training period is persistent, troublesome, associated with other urinary/bowel symptoms or causing functional impairment. Do not use age 5 as an absolute diagnostic threshold.

Normal voiding pattern in school-age child

Frequency (NICE CG111 definitions): more than 7 voids/day = increased frequency; fewer than 4 voids/day = infrequent voiding. Expected bladder capacity (ml) ≈ (age in years + 1) × 30 — an estimate only; do not use in isolation to diagnose pathology. Stream: continuous, without straining. Post-void dribble: minimal.

Primary vs secondary incontinence

Primary daytime incontinence: child has never achieved reliable daytime dryness. Causes: OAB (most common), detrusor instability, anatomical (ectopic ureter in girls — rare). Secondary daytime incontinence: new onset after at least 6 months of dryness. Causes: UTI, constipation, emotional stress/trauma, new-onset diabetes, psychological regression, safeguarding concerns, neurological (new cord pathology). Always investigate secondary incontinence more urgently.

The expected bladder capacity formula (age in years + 1) × 30 ml is an approximate estimate only — a 5-year-old ≈ (5+1)×30 = 180 ml, a 10-year-old ≈ (10+1)×30 = 330 ml — and should not be used in isolation to diagnose pathology. Children with overactive bladder (OAB) typically void smaller volumes more frequently than expected for their age. Bladder diaries (a 2-day frequency–volume recording of fluid intake, void times, voided volumes, urgency, leaks, stool frequency/consistency and soiling; the child should measure voided volumes if feasible — a structured diary is more useful than recall) are the gold standard assessment tool and are entirely achievable at home with simple equipment (a measuring jug in the bathroom). The ERIC (Education and Resources for Improving Childhood Continence) charity provides free downloadable bladder diary forms and is an excellent resource for GPs and families. Bladder diaries allow the GP or nurse to distinguish between: OAB (small frequent voids with urgency), voiding dysfunction (infrequent large voids with urgency and incomplete emptying), and normal voiding with access problems (adequate bladder capacity, normal frequency, just not reaching the toilet in time).

Diagnose

Assessment — History, Examination & Investigations

Done

History

Voiding pattern: void frequency, urgency (child suddenly needs to void, cannot defer), urgency urge incontinence (leaks before reaching toilet), post-void dribble, stream quality (intermittent, poor flow = dysfunctional). Bowel history: stool frequency, consistency (Bristol Stool Chart type 1-2 = constipated; types 6-7 = loose), soiling (encopresis). Fluid intake: adequate for age, body size, activity and climate? Caffeine intake (fizzy drinks, energy drinks — bladder irritants). Sleep: nocturnal enuresis (separate issue — see the nocturnal enuresis protocol). School: access to toilets (children often restrict fluids or delay voiding in school). Psychological: stressful life events, bullying, new sibling, parental separation; psychosocial/school impact. Also ask: daytime versus night-time wetting; primary versus secondary; holding manoeuvres; dysuria, fever, haematuria; straining, intermittency and post-void dribbling; neurological symptoms; polydipsia, polyuria, weight loss and fatigue.

Examination

Growth and blood pressure where clinically indicated. Abdomen: bladder or faecal mass (constipation — loaded sigmoid colon may be palpable in the left iliac fossa). Pelvic: avoid in primary care unless specific indication. External genitalia: only when clinically indicated and in accordance with safeguarding/paediatric protocols — in girls, labial adhesions (can cause post-void dribble from trapped urine), vulvovaginitis (irritation → urgency). Lumbosacral spine: sacral dimple, tuft of hair, lipoma (spinal dysraphism — refer; imaging via the paediatric team). Neurological lower limbs: tone, reflexes, sensation, gait. Observe stream if possible (boys in particular — poor stream, intermittent).

Investigations

Urine testing when there is recent-onset wetting, dysuria, frequency, urgency with pain, fever, abdominal/flank pain, haematuria, recurrent UTI, offensive urine, systemic illness, polyuria/polydipsia or diagnostic uncertainty — dipstick, with culture according to age, dipstick result and clinical risk; obtain samples before antibiotics where possible and manage per NICE NG224. Repeated MSU is not needed for longstanding typical functional wetting. Capillary glucose (if polyuria/polydipsia, weight loss or other diabetes symptoms). Bladder/bowel diary (2 days) — void times, voided volumes, urgency, leaks, fluid intake, stool frequency/consistency, soiling. No routine abdominal X-ray — constipation is diagnosed clinically (NICE CG99); consider specialist advice only if diagnosis remains uncertain, examination is unreliable or alternative pathology suspected. Renal/bladder USS per the NICE NG224 UTI imaging pathway, suspected structural abnormality, recurrent febrile or atypical UTI, abnormal stream, palpable abdominal/bladder mass, raised creatinine, urinary retention or specialist recommendation (include pre- and post-void bladder assessment in toilet-trained children where appropriate) — not for poor response of functional wetting alone. MCUG: not routine for daytime wetting or recurrent lower UTI — a specialist investigation in selected atypical/recurrent UTI or where ultrasound/clinical findings suggest reflux/obstruction.

The bladder diary is one of the most valuable and underused assessment tools in paediatric incontinence — it takes 2 days to complete, costs nothing, and provides information about voiding frequency, voided volumes, fluid intake, and incontinence episodes that cannot be obtained any other way. The practical approach: provide the family with a simple recording chart (the ERIC charity's bladder diary is freely downloadable at eric.org.uk), a measuring jug for the bathroom, and instructions. Ask them to complete it over one weekend and one school day. The results will immediately identify: whether fluid intake is adequate and whether voiding is infrequent (fewer than 4 voids/day); whether the voids are small and frequent (OAB pattern) or large and infrequent (voiding postponement/dysfunctional voiding); and whether the incontinence pattern correlates with urgency or occurs without warning. Without a bladder diary, the GP is working blind.

Diagnose

Subtypes of Daytime Incontinence — Clinical Patterns

Done

These are clinical working phenotypes, not definitive diagnoses.

Overactive bladder (OAB) — most common

Definition: urgency (sudden compelling desire to void) +/- urgency incontinence + increased voiding frequency. Pathophysiology: uninhibited detrusor contractions during bladder filling (before the bladder is full). Clinical features: child suddenly "needs to go" urgently, may cross legs, squat, perform holding manoeuvres. Small voided volumes on diary. Pain may be absent, but its absence does not exclude UTI — dysuria, fever, abdominal/flank pain or haematuria should prompt assessment for UTI or another cause. Associated with: constipation (loaded bowel compresses bladder + shares pudendal innervation). Treatment: standard urotherapy + timed voiding + treat constipation. Second-line: antimuscarinic via a paediatric continence/urology pathway.

Dysfunctional voiding (DV)

Child contracts the external urethral sphincter during voiding (instead of relaxing it). Causes incomplete emptying + high voiding pressure + turbulent flow. Suspect when there is infrequent voiding, straining, intermittent/staccato stream, prolonged voiding, recurrent UTI or persistent post-void dribbling. Do not diagnose from a bladder diary alone. Associated with: recurrent UTI (residual urine + high pressure), VUR, renal scarring. Refer for uroflowmetry with post-void residual and specialist continence/biofeedback assessment; double-voiding technique and pelvic floor relaxation support this.

Voiding postponement

Child ignores or overrides bladder signals until urgently needed — behavioural. Common in school-age children who do not want to leave class or play. Bladder diary: infrequent, large-volume voids. Normal uroflowmetry. No OAB features at home (when not distracted). Treatment: timed voiding schedule, school toilet access plan, reward chart.

Giggle incontinence (enuresis risoria)

Complete bladder emptying triggered by laughter. Predominantly in girls in the pre-pubertal and pubertal period. Mechanism: reflex detrusor contraction from laughter. No abnormality between episodes. A specialist diagnosis. Initial management is education and standard urotherapy; refractory cases may be referred to paediatric urology/continence services. Methylphenidate is off-label and should only be considered by a clinician experienced in paediatric continence/urology after specialist assessment.

The constipation-bladder connection is one of the most important and most overlooked relationships in paediatric incontinence — constipation commonly coexists with daytime urinary incontinence, and in some children treating the constipation improves the urinary symptoms. The anatomical mechanism: the loaded sigmoid colon and rectum lie immediately posterior to the bladder, and significant faecal loading mechanically compresses the bladder, reducing functional capacity and triggering premature detrusor contractions. The neurological mechanism: the sacral nerve roots (S2-S4) supply both the rectum/anal sphincter and the bladder/urethral sphincter — chronic rectal distension from constipation impairs normal bladder afferent signalling. The practical message: every child presenting with daytime urinary incontinence should have constipation actively assessed and treated before any bladder-specific pharmacological treatment is considered. The Bristol Stool Chart is a useful tool for assessing stool consistency with children.

Refer

Referral Pathways

Done

Same-day / urgent

New wetting with back pain or new neurological signs (leg weakness, saddle anaesthesia, gait or sensory change, abnormal reflexes) → same-day emergency paediatric assessment; spinal imaging via the emergency/paediatric team · Acute urinary retention → same-day emergency paediatric assessment · Suspected obstructive uropathy (poor stream, palpable bladder, renal impairment) → same day · Suspected T1DM (polyuria, polydipsia, weight loss) → same-day paediatric diabetes team (NICE NG18), do not wait for laboratory tests; 999 if drowsy, vomiting or breathless (suspected DKA) · Safeguarding emergency → MASH immediately

Paediatric urology / nephrology (prompt)

Continuous wetness from birth in a girl (ectopic ureter) · Poor or intermittent stream (e.g., posterior urethral valves in boys) · Recurrent febrile UTI · VUR with renal scarring · Abnormal renal/bladder ultrasound · Raised creatinine, hypertension or proteinuria · Significant post-void residual · Suspected dysfunctional voiding not responding to standard urotherapy · Persistent symptoms with abnormal examination. Follow NICE NG224 imaging and local specialist pathways.

Community paediatrics / paediatric continence service

Refer to the locally commissioned paediatric continence service where available; otherwise community paediatrics, paediatric urology or an equivalent local pathway. No meaningful improvement despite confirmed adherence and effective constipation treatment · OAB where antimuscarinic treatment is being considered · Suspected dysfunctional voiding (uroflowmetry + post-void residual + biofeedback)

School nurse / continence nurse specialist

Where locally commissioned (commissioning-dependent), a first-line route for functional daytime incontinence — continence nurses provide: bladder diary analysis, timed voiding plans, fluid advice, toilet access plans, reward chart guidance. Many ICBs have community paediatric continence nurse services accessible by GP referral.

GP management (first line)

UTI → treat per NICE NG224 (sample before antibiotics where possible). Constipation: disimpaction + maintenance per current CG99/product-specific guidance. Standard urotherapy: regular relaxed voiding every 2–3 hours while awake, adequate age-appropriate fluid intake, school support letter, positive non-punitive reinforcement. Antimuscarinic (oxybutynin) only after assessment by, or discussion with, a clinician experienced in paediatric bladder dysfunction. Do not use desmopressin for isolated daytime wetting. Do not initiate methylphenidate for giggle incontinence in general practice.

The referral to a paediatric continence nurse specialist is frequently the most appropriate and cost-effective first-line referral for functional daytime incontinence in primary care — these specialist nurses (increasingly available across UK NHS trusts and community services) have the time, expertise, and tools (bladder diary analysis software, uroflowmetry in some centres, reward chart and behaviour modification resources) to manage the majority of OAB and voiding postponement cases without requiring a paediatrician consultation. The ERIC charity emphasises that most childhood incontinence is manageable in community settings with nurse specialist support. Services are commissioning-dependent — GPs should check their local ICB continence service directory for the referral pathway. Paediatric urology should be reserved for structural abnormalities, refractory cases, and secondary incontinence with an identified organic cause.

Treat

Bladder Retraining & Constipation Treatment

Done

Timed voiding programme

The cornerstone of OAB and voiding postponement treatment. Use regular, relaxed toilet access, commonly every 2–3 hours while awake, tailored to the child’s diary and symptoms. Avoid encouraging either prolonged holding or unnecessarily frequent “just in case” voiding. Use a watch alarm or school alarm card (many schools will allow a discrete watch alarm in class). Rationale: interrupts the urgency-holding cycle; re-establishes cortical control over voiding; prevents bladder overdistension. Positive, non-punitive reinforcement for dry periods.

Double voiding technique

For dysfunctional voiding + post-void residual: void, wait 2-5 minutes on toilet (read, play on tablet), then void again. Reduces post-void residual. Reduces UTI risk from residual urine. Combined with relaxation of pelvic floor (feet flat on floor or on a stool — hips higher than knees position optimises pelvic floor relaxation).

Fluid intake optimisation

Adequate age-, body-size-, activity- and climate-appropriate fluid intake — NICE CG111 advises adequate daily fluid intake but no single universal volume. Reduce caffeine-containing drinks (cola, energy drinks, tea). Distribute fluids evenly through the day — drink most in morning and afternoon, reduce in late evening.

Constipation treatment

Use the current CG99/BNFC regimen for the specific macrogol product — check the product licence and age range, and use the exact local formulary wording for age bands. CG99 escalating disimpaction (macrogol 3350 + electrolytes paediatric sachets): age 1–4: 2 sachets on day 1, 4 daily for 2 days, 6 daily for 2 days, then 8 daily for 2 days; age 5–11: 4 sachets on day 1, increasing by 2 sachets daily to a maximum of 12 daily. Generally up to 7 days; review within 1 week — disimpaction is assessed clinically and soiling may increase initially. Maintenance: start as soon as the bowel is cleared (starting dose approximately half the disimpaction dose), titrated to regular soft stools; continue for several weeks or months after a regular bowel habit is achieved, then reduce gradually, not abruptly. Dietary fibre + adequate fluid support macrogol, but dietary measures alone are not adequate for faecal impaction.

The Movicol Paediatric disimpaction regimen is the NICE CG99 first-line treatment for faecal impaction in children — but it requires careful patient and parent education to succeed. Many parents are alarmed by the escalating dose regimen (up to 8 sachets per day) and the liquid stool that indicates successful disimpaction. Clear written instructions are essential: explain that the goal is to soften and clear the impacted stool, that the liquid stool (overflow) they may have seen from their child is a sign of severe constipation rather than diarrhoea, and that disimpaction is assessed clinically (soiling may increase initially). Review within 1 week. After disimpaction, maintenance laxative therapy (titrated to regular soft stools) must continue for several weeks or months after a regular bowel habit is achieved, then be reduced gradually. The most common reason for treatment failure in paediatric constipation is premature cessation of maintenance laxatives as soon as the child appears improved, followed by rapid reimpaction. Lactulose (second choice if macrogol not tolerated): 2.5–10 ml BD aged 1–4 years, 5–20 ml BD aged 5–17 years (check BNFC).

Treat

Pharmacological Management — Oxybutynin & Beyond

Done

Oxybutynin (anticholinergic)

Consider antimuscarinic treatment only after assessment by, or discussion with, a clinician experienced in paediatric bladder dysfunction, particularly where there is recurrent UTI, abnormal stream, suspected dysfunctional voiding, significant constipation or possible retention. Before prescribing: exclude/treat constipation, assess for UTI, consider dysfunctional voiding and residual urine, check contraindications (e.g., obstructive uropathy, GI motility disorders, myasthenia gravis), explain off-label status where applicable. Dose: per current SPC/BNFC and local paediatric formulary. Mechanism: antimuscarinic — inhibits uninhibited detrusor contractions. Side effects: dry mouth, constipation (worsens bladder symptoms), blurred vision, flushing, urinary retention, heat intolerance/hyperthermia, behavioural or cognitive anticholinergic effects, tachycardia, worsening incomplete emptying. Stop and seek specialist advice if urinary retention, severe abdominal distension, marked constipation, visual symptoms, confusion or significant adverse effects. Review at 4-6 weeks (bladder diary comparison, constipation, retention, adverse effects).

Modified-release oxybutynin / solifenacin

Specialist options only. Oxybutynin MR: once-daily dosing; product licensing varies — check the current SPC rather than assuming a licensed age. Solifenacin: product licensing varies — check the current SPC; used by paediatric urology centres for refractory OAB — not a routine next step. Antimuscarinics are not used as sole first-line treatment — standard urotherapy and constipation treatment must be established first.

Desmopressin (for nocturnal component)

Not part of the core treatment of isolated daytime incontinence — do not use for isolated daytime wetting. When nocturnal enuresis is also present, use the separate bedwetting pathway (NICE CG111). If used for the nocturnal component, follow the exact licensed product instructions: no substantial fluid from 1 hour before until 8 hours after the dose; omit during vomiting, diarrhoeal illness or significant intercurrent illness; stop and seek advice if headache, nausea, vomiting, confusion or seizures suggest hyponatraemia.

Methylphenidate for giggle incontinence

Methylphenidate is an off-label specialist treatment for selected refractory giggle incontinence (evidence mainly small studies/case series) and should not be initiated in general practice — refer to paediatric urology/continence services. If used: specialist initiation only; cardiovascular and neuropsychiatric assessment; controlled-drug governance; consider interaction with ADHD treatment; follow current BNFC/SPC and local shared-care arrangements.

Next steps: see Constipation (child) · Nocturnal enuresis · UTI in children

Oxybutynin is an effective treatment for paediatric OAB but its side-effect profile deserves specific attention in the context of constipation — constipation is both a cause of OAB (loaded bowel compressing the bladder) and a side effect of oxybutynin (anticholinergic effects reduce bowel motility). Starting oxybutynin without treating concurrent constipation will worsen the constipation, worsen the bladder symptoms, and create a vicious cycle. The correct approach: treat constipation first, achieve adequate bowel function, then reassess OAB symptoms (which may have resolved with constipation treatment alone). If OAB persists after constipation is treated: consider oxybutynin via a paediatric continence/urology pathway — but simultaneously intensify constipation treatment to counteract the anticholinergic bowel effect. Co-prescribing macrogol laxative alongside oxybutynin is standard practice in paediatric urology. At every review of a child on oxybutynin: ask specifically about constipation and stool frequency — if constipating, increase macrogol dose.

Lifestyle

Toilet Access, School Plans & Psychological Support

Done

School toilet access — the single biggest practical barrier Many children with daytime incontinence restrict fluids or delay voiding because school toilet access is inadequate (locked toilets, too few breaks, fear of bullying in toilets, not allowed to leave class). GPs can write a letter to the school requesting: unrestricted toilet access during lesson times (child should be allowed to leave class without asking permission), access to clean and safe toilets, privacy, adequate time at break. Ask the school for reasonable adjustments where the child’s continence problem substantially affects day-to-day activities (Equality Act 2010 assessment is individualised) — e.g., unrestricted toilet access, a discreet toilet pass, access to drinking water, spare clothing and a school healthcare/support plan. Involve the school nurse, SENCO and parents according to local arrangements.

School Individual Healthcare Plan (IHP) An IHP is not automatically required for every child with daytime wetting; where needed, request a school healthcare/support plan with the school nurse, SENCO and parents according to local arrangements. IHP documents: toilet access arrangements, fluid intake encouragement, spare clothes provision, teacher awareness without disclosure to classmates. GP and school nurse provide medical information for the IHP. This protects the child from embarrassment and ensures teachers respond appropriately.

Reward charts and positive reinforcement Reward dry periods rather than punishing wet episodes. Simple sticker chart: small reward (sticker, small toy) for each dry period. ERIC charity provides free downloadable reward charts. The goal is to build self-efficacy and reduce shame around accidents. Children with incontinence often develop significant anxiety and school avoidance — addressing the psychological impact is as important as treating the physiological cause.

Fluid intake at school Many children drink very little at school. Encourage a water bottle that goes to school and adequate age-, size-, activity- and climate-appropriate intake. Reduce caffeine-containing drinks (cola, energy drinks). Aim for pale straw-coloured urine.

Pelvic floor exercises for voiding dysfunction Children with dysfunctional voiding benefit from pelvic floor awareness — physiotherapy input or specialist nurse education. The "knack manoeuvre": teaching the child to pre-contract the pelvic floor in anticipation of a cough or sneeze prevents urgency incontinence. Relaxation position for voiding: feet flat on the floor (or stool under feet if toilet is too high) — hips level with or higher than knees. Girl scouts position (leaning slightly forward). Prevents pelvic floor tension during voiding.

Dietary management of constipation Soluble fibre: porridge oats, lentils, beans, fruit (especially kiwi — high in fibre and sorbitol, natural laxative). Insoluble fibre: wholemeal bread, vegetables. Water: adequate fluid is essential for fibre to work (fibre without fluid worsens constipation). Prune juice — contains sorbitol (natural osmotic laxative). Avoid: excess dairy, especially cheese and excessive cow's milk in toddlers (constipating). Diet supports, but does not replace, macrogol — dietary measures alone are not adequate for faecal impaction.

Psychological support for children with incontinence Ask about shame, bullying, distress, school avoidance and family responses. Offer psychological or CAMHS support when clinically indicated — clinically significant anxiety, depression, self-harm, school refusal or broader mental-health concerns; routine PHQ-A or RCADS screening is not required for every child. School counsellor involvement. ERIC helpline (0808 169 9949) — confidential support for children and parents. Normalise it as a common, treatable problem, while still assessing family stress, developmental needs and safeguarding. Avoid blame or punitive reward systems.

Siblings and family impact Incontinence in one child affects the whole family — siblings may tease, parents may become frustrated. Family education sessions (ERIC workshops). Address parental frustration and guilt explicitly: "This is not caused by bad parenting." Encourage age-appropriate self-management: older children can manage their own spare clothes and disposal of wet underwear (where possible) — builds autonomy and reduces dependence and shame.

The Equality Act 2010 protection for children with bladder and bowel conditions is an important advocacy tool that GPs can deploy — incontinence may be covered by the Equality Act when it meets the definition of a disability (a physical impairment with substantial long-term adverse effect on day-to-day activities) — the assessment is individualised — and schools should then make reasonable adjustments. In practice, many schools continue to deny children toilet access during lesson times, refuse to allow spare clothes to be kept in school, or embarrass children by requiring them to ask permission in front of classmates. A GP letter to the school requesting specific adjustments (unrestricted access, spare clothes, teacher briefing, IHP) has significant practical impact on the child's quality of life and treatment success. The ERIC charity provides a free template school letter for GPs to use, which can be personalised to the individual child.

Safety

Follow-Up, Treatment Response & Long-Term Monitoring

Done

Follow-up after initial management

Review after approximately 6–8 weeks, or earlier if symptoms worsen. Assess response using the diary (compared with baseline), bowel status, voiding pattern, fluid intake, adverse effects and school functioning. Refer or seek specialist advice if there is no meaningful improvement despite confirmed adherence and effective constipation treatment.

Oxybutynin monitoring

Review at 4-6 weeks: efficacy (bladder diary comparison) + side effects (dry mouth, constipation, urinary retention). Dose adjustment per specialist advice and current SPC/BNFC. Periodically trial off medication with specialist advice. If constipation worsens: increase macrogol dose. Stop and seek specialist advice if urinary retention, severe abdominal distension, marked constipation, visual symptoms, confusion or significant adverse effects.

Long-term prognosis

Most children improve with standard urotherapy and constipation treatment, but timescales vary — set realistic, individualised expectations. Dysfunctional voiding: specialist biofeedback + urotherapy. DV with VUR: requires long-term nephrology monitoring (renal function, blood pressure). Ectopic ureter: specialist follow-up.

When to discharge from follow-up

Discharge when symptoms have resolved and bowel habit is stable, judged individually. Advise parents: recurrence can occur at times of stress (new school, illness, family change) — re-refer promptly if needed. Leave the door open for re-referral.

Urgent referral

New wetting with back pain or new neurological signs → same-day emergency paediatric assessment (spinal imaging via that team) · Acute urinary retention → same-day emergency paediatric assessment · Continuous wetness from birth in a girl → prompt paediatric urology · Safeguarding concern → MASH immediate

Non-urgent referral

No meaningful improvement after 6–8 weeks despite confirmed adherence and effective constipation treatment → locally commissioned paediatric continence service · Recurrent febrile/atypical UTI + incontinence → imaging and referral per NICE NG224 and local specialist pathways (not automatic renal USS + nephrology) · Suspected DV (straining, staccato stream, infrequent voids, UTIs) → paediatric urology/continence (uroflowmetry + post-void residual)

Most children with OAB improve with appropriate treatment (standard urotherapy + constipation management ± specialist-guided medication), although timescales vary. Give families realistic, individualised expectations. The important caveats: (1) dysfunctional voiding with VUR and renal scarring requires long-term nephrology monitoring because VUR-associated reflux nephropathy can cause chronic kidney disease and hypertension in adulthood even after the voiding pattern has normalised; (2) children with an underlying neurological cause (tethered cord, spinal dysraphism) may have persistent bladder dysfunction requiring lifelong urological management; and (3) DLD and ASD are commonly associated with continence difficulties that persist longer than in neurotypical children and require adapted approaches.